5 Amendments of Stelios KOULOGLOU related to 2018/2775(RSP)
Amendment 24 #
Recital K
K. whereas there is limited evidence that cannabis or cannabinoids are effective for increasing appetite and decreasing weight loss associated with HIV/AIDS, improving clinician-measured multiple sclerosis spasticity symptoms, improving symptoms of Tourette syndrome, improving symptoms of posttraumatic stress disorder; but also Alzheimer’s, Arthritis, Asthma, Cancer, Crohn’s disease, Epilepsy, and Glaucoma and it contributes to the reduction of the risk of obesity and diabetes, mitigates menstrual pain and helps in processes of anxiety and depression.
Amendment 28 #
Recital M a (new)
Ma. whereas the global market for medicinal cannabis in 2015 reached $11, 4 billion, and in 2025, it is expected to reach $52, 8 billion. The market for cannabidiol (CBD) products for medicines, food and supplements is expected to grow by 700% by 2020, reaching $2,1billion in total. In Greece, 10 millions € in the pharmaceutical cannabis sector are expected as a surplus from the decriminalisation of cannabis for medicinal use in the near future. While it is estimated that 7,000 new jobs will be created and 2000 in the countryside for plant cultivation.
Amendment 31 #
Recital N a (new)
Na. whereas, the decriminalization of cannabis in many countries, has reduced both the black market and criminal activities. Bearing also in mind, that patients end up in prison for possession of a small amount of cannabis for medicinal use. As a consequence national judicial authorities are overburdened by such cases.
Amendment 57 #
Paragraph 5 a (new)
5a. Calls on the Commission to create a department on cannabis for therapeutic use to have a place to centralize regulatory proposals and be the point of observation, advice, information, exchange and study for everything related which would serve as a reference to all countries equally in the European Union.
Amendment 58 #
Paragraph 5 a (new)